Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods
About this event
Over the past few years, the mass spectrometry-based Multi-Attribute Method (MAM) has gained traction due to its potential to streamline lab work and decrease development time. However, several barriers to adoption remain, one of which is evaluating performance of MAM vs. conventional methods.
To evaluate the performance of MAM vs conventional methods, adalimumab and. Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods is an official on-demand session listing associated with BioPharma Webinars.
Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions. UPCOMING provides this independent listing to help professionals discover the session.
Topics covered
Frequently asked questions
Who is hosting Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods?
Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods is hosted by BioPharma Webinars.
When is Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods?
Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods is scheduled for Monday, April 28, 2025.
Where does registration take place?
Registration or viewing is completed on BioPharma Webinars's website.
What format is this event?
This is an online webinar.
Which topics does this event cover?
The event covers SaaS.
More from 888 Publishing
View all →
Available on demand
Aggregation Analysis in AAV: Selecting Fit-for-Purpose Assays
888 Publishing
Available on demand
Enhancing Plasmid DNA Quality Through Robust Topology Measurement
888 Publishing
Available on demand
Characterization of Lipid Nanoparticles Using Macro Mass Photometry Insights into Size & Mass
888 Publishing